RELEASE: a protocol for a systematic review based, individual participant data, meta- and network meta-analysis, of complex speech-language therapy interventions for stroke-related aphasia.

IPD Stroke aphasia complex intervention meta-analysis

Journal

Aphasiology
ISSN: 0268-7038
Titre abrégé: Aphasiology
Pays: England
ID NLM: 8708531

Informations de publication

Date de publication:
Feb 2020
Historique:
medline: 1 2 2020
pubmed: 1 2 2020
entrez: 10 8 2023
Statut: ppublish

Résumé

Speech and language therapy (SLT) benefits people with aphasia following stroke. Group level summary statistics from randomised controlled trials hinder exploration of highly complex SLT interventions and a clinically relevant heterogeneous population. Creating a database of individual participant data (IPD) for people with aphasia aims to allow exploration of individual and therapy-related predictors of recovery and prognosis. To explore the contribution that individual participant characteristics (including stroke and aphasia profiles) and SLT intervention components make to language recovery following stroke. We will identify eligible IPD datasets (including randomised controlled trials, non-randomised comparison studies, observational studies and registries) and invite their contribution to the database. Where possible, we will use meta- and network meta-analysis to explore language performance after stroke and predictors of recovery as it relates to participants who had no SLT, historical SLT or SLT in the primary research study. We will also examine the components of effective SLT interventions. Outcomes include changes in measures of functional communication, overall severity of language impairment, auditory comprehension, spoken language (including naming), reading and writing from baseline. Data captured on assessment tools will be collated and transformed to a standardised measure for each of the outcome domains. Our planned systematic-review-based IPD meta- and network meta-analysis is a large scale, international, multidisciplinary and methodologically complex endeavour. It will enable hypotheses to be generated and tested to optimise and inform development of interventions for people with aphasia after stroke. The protocol has been registered at the International Prospective Register of Systematic Reviews (PROSPERO; registration number: CRD42018110947).

Sections du résumé

Background UNASSIGNED
Speech and language therapy (SLT) benefits people with aphasia following stroke. Group level summary statistics from randomised controlled trials hinder exploration of highly complex SLT interventions and a clinically relevant heterogeneous population. Creating a database of individual participant data (IPD) for people with aphasia aims to allow exploration of individual and therapy-related predictors of recovery and prognosis.
Aim UNASSIGNED
To explore the contribution that individual participant characteristics (including stroke and aphasia profiles) and SLT intervention components make to language recovery following stroke.
Methods and procedures UNASSIGNED
We will identify eligible IPD datasets (including randomised controlled trials, non-randomised comparison studies, observational studies and registries) and invite their contribution to the database. Where possible, we will use meta- and network meta-analysis to explore language performance after stroke and predictors of recovery as it relates to participants who had no SLT, historical SLT or SLT in the primary research study. We will also examine the components of effective SLT interventions.
Outcomes and results UNASSIGNED
Outcomes include changes in measures of functional communication, overall severity of language impairment, auditory comprehension, spoken language (including naming), reading and writing from baseline. Data captured on assessment tools will be collated and transformed to a standardised measure for each of the outcome domains.
Conclusion UNASSIGNED
Our planned systematic-review-based IPD meta- and network meta-analysis is a large scale, international, multidisciplinary and methodologically complex endeavour. It will enable hypotheses to be generated and tested to optimise and inform development of interventions for people with aphasia after stroke.
Systematic review registration UNASSIGNED
The protocol has been registered at the International Prospective Register of Systematic Reviews (PROSPERO; registration number: CRD42018110947).

Identifiants

pubmed: 37560459
doi: 10.1080/02687038.2019.1643003
pmc: PMC7614912
mid: EMS151068
doi:

Types de publication

Journal Article

Langues

eng

Pagination

137-157

Références

BMC Med Res Methodol. 2012 Apr 24;12:56
pubmed: 22530717
Lancet. 2012 Feb 4;379(9814):432-44
pubmed: 22152853
BMJ. 2015 Jan 02;350:g7647
pubmed: 25555855
Stat Methods Med Res. 2018 May;27(5):1351-1364
pubmed: 27487843
Stroke. 2003 Apr;34(4):987-93
pubmed: 12649521
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
Disabil Rehabil. 2017 Jul;39(14):1364-1379
pubmed: 27345867
J Clin Epidemiol. 2017 Oct;90:43-50
pubmed: 28720516
Eur Neurol. 2012;68(4):199-208
pubmed: 22948550
Restor Neurol Neurosci. 2015;33(2):115-20
pubmed: 25588456
J Clin Epidemiol. 2011 Apr;64(4):380-2
pubmed: 21185693
Cochrane Database Syst Rev. 2016 Jun 01;(6):CD000425
pubmed: 27245310
Int J Evid Based Healthc. 2015 Sep;13(3):132-40
pubmed: 26360830
BMJ. 2014 Mar 07;348:g1687
pubmed: 24609605
Ann Intern Med. 2015 Jun 2;162(11):777-84
pubmed: 26030634
Int J Stroke. 2019 Feb;14(2):180-185
pubmed: 30303810
BMJ. 2009 Jul 21;339:b2535
pubmed: 19622551
JAMA. 2015 Apr 28;313(16):1657-65
pubmed: 25919529

Auteurs

Marian C Brady (MC)

Nursing Midwifery and Allied Health Professions Unit, Glasgow Caledonian University, Glasgow, UK.

Myzoon Ali (M)

Nursing Midwifery and Allied Health Professions Unit, Glasgow Caledonian University, Glasgow, UK.

Kathryn VandenBerg (K)

Nursing Midwifery and Allied Health Professions Unit, Glasgow Caledonian University, Glasgow, UK.

Linda J Williams (LJ)

Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK.

Louise R Williams (LR)

Nursing Midwifery and Allied Health Professions Unit, Glasgow Caledonian University, Glasgow, UK.

Masahiro Abo (M)

Department of Rehabilitation Medicine, The Jikei University School of Medicine, Tokyo, Japan.

Frank Becker (F)

University of Oslo, Oslo, and Sunnaas Rehabilitation Hospital, Bjørnemyr, Norway.

Audrey Bowen (A)

Division of Neuroscience & Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, UK.

Caitlin Brandenburg (C)

School of Health and Rehabilitation Sciences, The University of Queensland, Brisbane, Australia.

Caterina Breitenstein (C)

Department of Neurology with Institute of Translational Neurology, University of Muenster, Muenster, Germany.

Stefanie Bruehl (S)

School of Biological Sciences, University of Manchester, Manchester, UK.

David A Copland (DA)

School of Health and Rehabilitation Sciences, The University of Queensland, Brisbane, Australia.

Tamara B Cranfill (TB)

Special Education, Eastern Kentucky University, Richmond, KY, USA.

Marie di Pietro-Bachmann (MD)

Division of Neurorehabilitation, Department of Clinical Neurosciences, University Hospitals and University of Geneva, Geneva, Switzerland.

Pamela Enderby (P)

School of Health and Related Research, University of Sheffield, Sheffield, UK.

Joanne Fillingham (J)

Nursing Directorate, NHS Improvement, London, UK.

Federica Lucia Galli (FL)

Neurorehabilitation Clinic, Neurological Sciences Department, Marche Polytechnic University, Ancona, Italy.

Marialuisa Gandolfi (M)

Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.

Bertrand Glize (B)

EA 4136 Handicap Activity Cognition Health, University of Bordeaux and Department of Physical Medicine and Rehabilitation, CHU de Bordeaux, France.

Erin Godecke (E)

School of Medical and Health Sciences, Edith Cowan University, Joondalup, Australia.

Neil Hawkins (N)

Institute of Health & Wellbeing, University of Glasgow, Glasgow, UK.

Katerina Hilari (K)

Division of Language and Communication Science, City, University of London, London, UK.

Jacqueline Hinckley (J)

Department of Speech-Language Pathology, Nova Southeastern University, Fort Lauderdale, FL, USA.

Simon Horton (S)

School of Health Sciences, University of East Anglia, Norwich, UK.

David Howard (D)

School of Education Communication and Language Sciences, Newcastle University, Newcastle-Upon-Tyne, UK.

Petra Jaecks (P)

Faculty of Linguistics and Literary Studies, Bielefeld University, Bielefeld, Germany.

Elizabeth Jefferies (E)

Department of Psychology, University of York, York, UK.

Luis M T Jesus (LMT)

School of Health Sciences (ESSUA) and Institute of Electronics and Informatics Engineering of Aveiro (IEETA), University of Aveiro, Aveiro, Portugal.

Maria Kambanaros (M)

Department of Rehabilitation Sciences, Cyprus University of Technology, Limassol, Cyprus.

Eun Kyoung Kang (EK)

Department of Rehabilitation Medicine, Kangwon National University Hospital, Chuncheon, Republic of Korea.

Eman M Khedr (EM)

Department of Neurology, Assiut University Hospital, Assiut, Egypt.

Anthony Pak-Hin Kong (AP)

School of Communication Sciences and Disorders, University of Central Florida, Orlando, FL, USA.

Tarja Kukkonen (T)

ENT/Department of Phoniatry, Tampere University Hospital, Tampere, Finland.

Marina Laganaro (M)

Faculty of Psychology and Educational Science, University of Geneva, Geneva, Switzerland.

Matthew A Lambon Ralph (MAL)

MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK.

Ann Charlotte Laska (AC)

Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden.

Béatrice Leemann (B)

Neurorééducation, Département des Neurosciences Cliniques, Hôpitaux Universitaires de Genève, Geneva, Switzerland.

Alexander P Leff (AP)

Department of Brain Repair and Rehabilitation, Institute of Neurology, UCL, London, UK.

Roxele R Lima (RR)

Department of Speech Language Pathology, Educational Association Bom Jesus - IELUSC, Santa Catarina, Brazil.

Antje Lorenz (A)

Institut für Psychologie, Humboldt University Berlin, Berlin, Germany.

Brian MacWhinney (B)

Department of Psychology, Carnegie Mellon University, Pittsburgh, PA, USA.

Rebecca Shisler Marshall (RS)

Department of Communication Sciences and Special Education, University of Georgia, Georgia, USA.

Flavia Mattioli (F)

Neuropsychology Unit, ASST Spedali Civili of Brescia, Brescia, Italy.

Ilknur Maviş (I)

Department of Speech and Language Therapy, Anadolu University, Eskişehir, Turkey.

Marcus Meinzer (M)

UQ Centre for Clinical Research, The University of Queensland, Hertston, Australia.

Reza Nilipour (R)

Department of Speech Therapy, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.

Enrique Noé (E)

NEURORHB-Hospitales Vithas, Valencia, Spain.

Nam-Jong Paik (NJ)

Department of Rehabilitation Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.

Rebecca Palmer (R)

School of Health and Related Research, University of Sheffield, Sheffield, UK.

Ilias Papathanasiou (I)

Department of Speech and Language Therapy, Technological Educational Institute of Western Greece, Patras, Greece.

Brigida F Patricio (BF)

Speech Therapy Department of Health School of Polytechnic Institute of Porto, Porto, Portugal.

Isabel Pavão Martins (IP)

Laboratório de Estudos de Linguagem, Faculdade de Medicina de Lisboa, Universidade de Lisboa, Lisbon, Portugal.

Cathy Price (C)

Wellcome Centre for Human Neuroimaging, UCL, London, UK.

Tatjana Prizl Jakovac (TP)

Department of Speech and Language Pathology, Faculty of Education and Rehabilitation Sciences, University of Zagreb, Zagreb, Croatia.

Elizabeth Rochon (E)

Department of Speech-Language Pathology and Rehabilitation Sciences Institute, University of Toronto, and Toronto Rehabilitation Institute, Toronto, Canada.

Miranda L Rose (ML)

School of Allied Health, La Trobe University, Melbourne, Australia.

Charlotte Rosso (C)

Institut du Cerveau et del la Moelle épinière, Sorbonne University, APHP, Urgences Cérébro-Vasculaires, Hôpital de la Pitié Salpêtrière, Paris, France.

Ilona Rubi-Fessen (I)

RehaNova Rehabilitation Hospital and Department of Special Education and Rehabilitation, University of Cologne, Cologne, Germany.

Marina B Ruiter (MB)

Sint Maartenskliniek, Rehabilitation Centre and Centre for Language Studies, Radboud University, Nijmegen, The Netherlands.

Claerwen Snell (C)

Warrington Hospital, Warrington and Halton NHS Foundation Trust, Warrington, UK.

Benjamin Stahl (B)

Department of Neurology, Charité Universitätsmedizin Berlin, Berlin, Germany.

Jerzy P Szaflarski (JP)

UAB Epilepsy Centre, Department of Neurology, University of Alabama at Birmingham, AL, USA.

Shirley A Thomas (SA)

Division of Rehabilitation & Ageing; School of Medicine, University of Nottingham, Nottingham, UK.

Mieke van de Sandt-Koenderman (M)

Rijndam rehabilitation Rotterdam and Erasmus University Medical Center, Rotterdam, Netherlands.

Ineke van der Meulen (I)

Rijndam rehabilitation Rotterdam and Erasmus University Medical Center, Rotterdam, Netherlands.

Evy Visch-Brink (E)

Department of Neurology and Neurosurgery, Erasmus University Medical Center, Rotterdam, Netherlands.

Linda Worrall (L)

School of Health and Rehabilitation Sciences, The University of Queensland, Brisbane, Australia.

Heather Harris Wright (HH)

College of Allied Health Sciences, East Carolina University, Greenville, SC, USA.

Classifications MeSH